Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigations in young women: A report of six cases

Human Reproduction

Volumn 24, Issue 5, 2009, Pages 1045-1050

  Fujiwara, H ^a   Ogawa, S ^b   Motoyama, M ^b   Takei, Y ^a   MacHida, S ^a   Taneichi, A ^a   Ohwada, M ^a   Suzuki, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Institute for Tochigi Central Clinic   (Japan)

Author keywords

Diagnosis; Endometrial carcinoma; Overall incidence; Routine infertility investigations

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CLINICAL ARTICLE; EARLY CANCER; EARLY DIAGNOSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GYNECOLOGICAL EXAMINATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; JAPANESE; MEDICAL EXAMINATION; PERIODIC MEDICAL EXAMINATION; UTERUS;

EID: 67449155866     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep002     Document Type: Article

References (32)

1. Ajiki W, Kinoshita N, Tsukuma H, Oshima A. Cancer incidence and incidence rates in Japan in 1995: estimates based on data from nine population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan, jpn j Clin Oncol 2000; 30:318 321.
2. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wiibanks GD, Lannom L. Hoover RN. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992; 167:1317- 1325.
3. Brown SE, Coddington CC, Schnorr J, Toner JP, Gibbons W. Oehninger S. Evaluation of outpatient hysteroscopy, saline infusion hysterosonography, and hysterosalpingography in infertile women: a prospective, randomized study. Fertil Steril 2000;74:1029- 1034.
4. Clark TJ. Outpatient hysteroscopy and ultrasonography in the management of endometrial disease. Curr Opin Obstet Gynecol 2004; 16:305--3 11.
5. Clark TJ, Voit D, Gupta JK. Hyde C, Song F. Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1 610- 1 621.
6. Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 198l;57: 699-704.
7. Eng CW, Tang PH, Ong CL. Hysterosalpingography: current applications. Singapore Med j 2007:48:368-373.
8. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417-420.
9. Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995; 85:504-508.
10. Gotlieb WH, Beiner ME, Shalmon B, Korach Y. Segal Y. Zmira N, Koupolovic J, Ben-Baruch G. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003:102:718- 725.
11. Gusberg SB, Milano C. Detection of endometrial cancer and its precursors. Cancer 1981;47:l 173-1 175.
12. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for atients with adenocarcinoma of the endometrium who wish to preserve the uterus usefulness and limitations. Eur J Gynaecol Oncol 2001 ;22:217-220.
13. Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, Kuwabara Y, Hataeg M, Kodama S, Kuzuya K, Sato S et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 2001;167:39-48.
14. Kelekci S. Kaya E, Alan M, Alan Y. Bilge U, Mollamahmutoglu L Comparison of transvaginal sonography, saline infusion sonography, and office hysteroscopy in reproductive-aged women with or without abnormal uterine bleeding. Fertil Steril 2005;84:682-686.
15. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997:79:320-327.
16. Kim YB, Ghosh K, Ainbinder S, Berek JS. Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer. Cancer Treat Res 1998:95:253-276.
17. Koss LG. Detection of occult endometrial carcinoma. J Cell Blochem Suppl 1995;23:165-173.
18. Kurabayashi T. Kase H, Suzuki M, Sugaya S. Fujita K, Tanaka K. Endometrial abnormalities in infertile women. J Reprod Med 2003;48:455-459.
19. Lurain JR. Uterine cancer. In: Berek JS (ed). Berek & Novak's gynecology. Philadelphia, USA: Lippincott Williams & Wilkins, 2007, 1343-1401.
20. Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2000: estimates based on data from I I population-based cancer registries. Jpn J Clin Oncol 2006; 36:668-675.
21. Menczer J, Frenkel Y, Serr DM. Hysterosalpingography in young infertile patients with unsuspected endometrial adenocarcinoma. Am J Obstet Gynecol 1980:138:352-353.
22. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991 a;41:1 - 16.
23. Parazzini F, La Vecchia C, Negri E. Fedele L. Balotta F. Reproductive factors and risk of endometrial cancer. Am j Obstet Gynecol 1991b; 164:522-527.
24. Rackow BW, Arici A. Endometrial cancer and fertility. Curr Opin Obstet Gynecol 2006; 18:245-252.
25. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997:90:434-440.
26. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;33S: 1134 (Epub 6 November 2007).
27. Roma Dalfó A, Ubeda B, Ubeda A, Monzón M, Rotger R, Ramos R. Palacio A. Diagnostic value of hysterosalpingography in the detection of intrauterine abnormalities: a comparison with hysteroscopy. AJR Am j Roentgenol 2004; 183:1405-1409.
28. Sawicki W, Spiewankiewicz B, Stelmachów J, Cendrowski K. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer. Eur j Gynaecol Oncol 2003;24:293-298.
29. Smith RA. von Eschenbach AC, Wender R, Levin B, Byers T. Rothenberger D, Brooks D, Creasman W, Cohen C. Runowicz C et ai, ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75.
30. Sorosky JI. Endometrial cancer. Obstet Gynecol 2008; 111:436-447.
31. Ushijima K, Yahata H, Yoshlkawa H, Konlshi I, Yasugl T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T et al. Multicenter phase Il study of fertility sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 2007;25:2798-2803.
32. Williams PL, Laifer-Narin SL, Ragavendra N. US of abnormal uterine bleeding. Radiographics 2003:23:703 718.